AAAAAA

   
Results: 1-19 |
Results: 19
Prostate Cancer: What is the future role for imaging?
Authors: Thornbury, JR Ornstein, DK Choyke, PL Langlotz, CP Weinreb, JC
Citation: Jr. Thornbury et al., Prostate Cancer: What is the future role for imaging?, AM J ROENTG, 176(1), 2001, pp. 17-22
Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium
Authors: Ornstein, DK Cinquanta, M Weiler, S Duray, PH Emmert-Buck, MR Vocke, CD Linehan, WM Ferretti, JA
Citation: Dk. Ornstein et al., Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium, J UROL, 165(4), 2001, pp. 1329-1334
Genetic alterations in prostatic intraepithelial neoplasia (PIN)
Authors: Duray, PH Ornstein, DK Vocke, CD Hewitt, SM Cole, KA Gillespie, JW Englert, CR Petricoin, EF Krizman, DB Linehan, WM Emmert-Buck, MR
Citation: Ph. Duray et al., Genetic alterations in prostatic intraepithelial neoplasia (PIN), CONT CANC R, 2001, pp. 141-161
Molecular profiling of clinical tissue specimens - Feasibility and applications
Authors: Emmert-Buck, MR Strausberg, RL Krizman, DB Bonaldo, MF Bonner, RF Bostwick, DG Brown, MR Buetow, KH Chuaqui, RF Cole, KA Duray, PH Englert, CR Gillespie, JW Greenhut, S Grouse, L Hillier, LW Katz, KS Klausner, RD Kuznetzov, V Lash, AE Lennon, G Linehan, WM Liotta, LA Marra, MA Munson, PJ Ornstein, DK Prabhu, VV Prange, C Schuler, GD Soares, MB Tolstoshev, CM Vocke, CD Waterston, RH
Citation: Mr. Emmert-buck et al., Molecular profiling of clinical tissue specimens - Feasibility and applications, J MOL DIAGN, 2(2), 2000, pp. 60-66
Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium
Authors: Ornstein, DK Englert, C Gillespie, JW Paweletz, CP Linehan, WM Emmert-Buck, MR Petricoin, EF
Citation: Dk. Ornstein et al., Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium, CLIN CANC R, 6(2), 2000, pp. 353-356
Geographic variation in patient surveillance after radical prostatectomy
Authors: Powell, TM Thompsen, JP Virgo, KS Johnson, ET Chan, D Colberg, JW Ornstein, DK Johnson, FE
Citation: Tm. Powell et al., Geographic variation in patient surveillance after radical prostatectomy, ANN SURG O, 7(5), 2000, pp. 339-345
How tumor stage affects American urologists' surveillance strategies afterprostate cancer surgery
Authors: Johnson, FE Virgo, KS Ornstein, DK Johnson, ET Chan, D Colberg, JW
Citation: Fe. Johnson et al., How tumor stage affects American urologists' surveillance strategies afterprostate cancer surgery, INT J ONCOL, 16(6), 2000, pp. 1221-1225
An approach to proteomic analysis of human tumors
Authors: Emmert-Buck, MR Gillespie, JW Paweletz, CP Ornstein, DK Basrur, V Appella, E Wang, QH Huang, J Hu, N Taylor, P Petricoin, EF
Citation: Mr. Emmert-buck et al., An approach to proteomic analysis of human tumors, MOL CARCINO, 27(3), 2000, pp. 158-165
Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip
Authors: Paweletz, CP Gillespie, JW Ornstein, DK Simone, NL Brown, MR Cole, KA Wang, QH Huang, J Hu, N Yip, TT Rich, WE Kohn, EC Linehan, WM Weber, T Taylor, P Emmert-Buck, MR Liotta, LA Petricoin, EF
Citation: Cp. Paweletz et al., Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip, DRUG DEV R, 49(1), 2000, pp. 34-42
Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines
Authors: Ornstein, DK Gillespie, JW Paweletz, CP Duray, PH Herring, J Vocke, CD Topalian, SL Bostwick, DG Linehan, WM Petricoin, EF Emmert-Buck, MR
Citation: Dk. Ornstein et al., Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines, ELECTROPHOR, 21(11), 2000, pp. 2235-2242
A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: Impact on cancer detection
Authors: Naughton, CK Miller, DC Mager, DE Ornstein, DK Catalona, WJ
Citation: Ck. Naughton et al., A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: Impact on cancer detection, J UROL, 164(2), 2000, pp. 388-392
Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer
Authors: Ornstein, DK Lubensky, IA Venzon, D Zbar, B Linehan, WM Walther, MM
Citation: Dk. Ornstein et al., Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer, J UROL, 163(2), 2000, pp. 431-433
Pain and morbidity of transrectal ultrasound guided prostate biopsy: A prospective randomized trial of 6 versus 12 cores
Authors: Naughton, CK Ornstein, DK Smith, DS Catalona, WJ
Citation: Ck. Naughton et al., Pain and morbidity of transrectal ultrasound guided prostate biopsy: A prospective randomized trial of 6 versus 12 cores, J UROL, 163(1), 2000, pp. 168-171
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma
Authors: Paweletz, CP Ornstein, DK Roth, MJ Bichsel, VE Gillespie, JW Calvert, VS Vocke, CD Hewitt, SM Duray, PH Herring, J Wang, QH Hu, N Linehan, WM Taylor, PR Liotta, LA Emmert-Buck, MR Petricoin, EF
Citation: Cp. Paweletz et al., Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma, CANCER RES, 60(22), 2000, pp. 6293-6297
Molecular profiling of clinical tissue specimens - Feasibility and applications
Authors: Emmert-Buck, MR Strausberg, RL Krizman, DB Bonaldo, MF Bonner, RF Bostwick, DG Brown, MR Buetow, KH Chuaqui, RF Cole, DA Duray, PH Englert, CR Gillespie, JW Greenhut, S Grouse, L Hillier, LW Katz, KS Klausner, RD Kuznetzov, V Lash, AE Lennon, G Linehan, WM Liotta, LA Marra, MA Munson, PJ Ornstein, DK Prabhu, VV Prange, C Schuler, GD Soares, MB Tolstoshev, CM Vocke, CD Waterston, RH
Citation: Mr. Emmert-buck et al., Molecular profiling of clinical tissue specimens - Feasibility and applications, AM J PATH, 156(4), 2000, pp. 1109-1115
Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer
Authors: Ornstein, DK Beiser, JA Andriole, GL
Citation: Dk. Ornstein et al., Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer, BJU INT, 83(1), 1999, pp. 43-46
Testicular androgen ablation for prostate cancer - Reply
Authors: Ornstein, DK Andriole, GL
Citation: Dk. Ornstein et Gl. Andriole, Testicular androgen ablation for prostate cancer - Reply, UROLOGY, 54(1), 1999, pp. 194-194
Current followup strategies after radical prostatectomy: A survey of American Urological Association Urologists
Authors: Oh, J Colberg, JW Ornstein, DK Johnson, ET Chan, D Virgo, KS Johnson, FE
Citation: J. Oh et al., Current followup strategies after radical prostatectomy: A survey of American Urological Association Urologists, J UROL, 161(2), 1999, pp. 520-523
The age of the urologist affects the postoperative care of prostate carcinoma patients
Authors: Tsai, DY Virgo, KS Colberg, JW Ornstein, DK Johnson, ET Chan, D Johnson, FE
Citation: Dy. Tsai et al., The age of the urologist affects the postoperative care of prostate carcinoma patients, CANCER, 86(7), 1999, pp. 1314-1321
Risultati: 1-19 |